TG Therapeutics (TGTX) Earnings Announcement Set for November 4
Nov 2, 2024
Biopharmaceutical Investment Portfolios
CytoMed Therapeutics Announces Financial Results for First Half of 2024, Provides Updates on Clinical Progress and Corporate Developments
Oct 1, 2024
Entrada Therapeutics Elevates Natarajan Sethuraman to President of R&D amid EEV-Therapeutics Pursuits
Sep 25, 2024
GENFIT Releases H1 2024 Financial Results with Corporate Update
Sep 20, 2024
Liquidia Corporation Secures $67.5M in Stock Financings and Advances
Sep 12, 2024
Unicycive Therapeutics to Showcase Research at ASN Kidney Week 2024
Aug 26, 2024
Unicycive Announces Robust Second Quarter 2024 Financial Results and Business Progress
Aug 15, 2024
Avicanna Inc. Announces Auditor Transition
Aug 3, 2024
Entrada Therapeutics' Composite Rating Climbs, Signaling Investment Opportunity Amid Biopharma Stocks
Jul 13, 2024
Anavex Life Sciences to Highlight Advances at H.C. Wainwright Neuro Conference
Jun 21, 2024
Silo Pharma Initiates $2 Million Registered Direct Offering
Jun 6, 2024
MiNK Therapeutics Schedules Virtual Annual Shareholders Meeting Amidst Pioneering Cancer Therapies Development
Jun 5, 2024
Exploring the Momentum of Context Therapeutics Inc. for Investors
May 21, 2024
CytoMed Therapeutics Announces Cell Banking Service for Shareholders Anticipating Future Precision Medicine Advancements
Mar 19, 2024
Citius Pharmaceuticals, Inc. Receives $2.4 Million Boost from NJ Economic Development Initiative
Mar 7, 2024
Liquidia Corporation to Announce Full Year 2023 Financial Performance
Mar 6, 2024
CytoMed Therapeutics Partners with Sengkang General Hospital to Pioneer Stem Cell Therapy for Cartilage Repair
Mar 4, 2024
Avicanna Ventures into a New Research Partnership with Leading European Pharmaceutical Firm
Feb 16, 2024
Cingulate Inc. Announces $7.5 Million Public Offering
Feb 3, 2024
TC BioPharm CEO Bryan Kobel Discusses Company's Future on 'The Big Biz Show'
Jan 30, 2024
Werth Family Investment Associates Transforms $3.3M Debt into Cingulate Inc. Equity at Above Market Value
Jan 29, 2024
XORTX Therapeutics Inc. Launches $2 Million Public Offering
Jan 15, 2024
Molecular Partners Announces Key Pipeline Updates at J.P. Morgan Healthcare Conference
Jan 8, 2024
Neumora Therapeutics Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
Jan 3, 2024
Hawaiian Airlines Soars on Acquisition News; Diverse Pre-Market Stock Movements Observed
Dec 4, 2023
Athira Pharma Reports Promising Preclinical Data for Alzheimer's Treatment Candidate Fosgonimeton
Nov 15, 2023
Brooklyn ImmunoTherapeutics Initiated with Hold Rating by StockNews.com Amid Market Movements of Noted Stocks ERNA, MDB, and PLUG
Nov 13, 2023
StockNews.com Issues Sell Rating for Minerva Neurosciences NERV
Nov 12, 2023
Ardelyx to Showcase at Jefferies London Healthcare Conference
Nov 11, 2023
Ardelyx to Engage in the Jefferies London Healthcare Conference
Nov 11, 2023